258 related articles for article (PubMed ID: 21508695)
1. Adjuvant treatment of advanced-stage endometrial cancer.
Lee NK
Clin Obstet Gynecol; 2011 Jun; 54(2):256-65. PubMed ID: 21508695
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant treatment for endometrial cancer: literature review and recommendations by the Comité de l'évolution des pratiques en oncologie (CEPO).
Morneau M; Foster W; Lalancette M; Van Nguyen-Huynh T; Renaud MC; Samouëlian V; Letarte N; ; ; Almanric K; Boily G; Bouchard P; Boulanger J; Cournoyer G; Couture F; Gervais N; Goulet S; Guay MP; Kavanagh M; Lemieux J; Lespérance B; Letarte N; Morneau M; Ouellet JF; Pineau G; Rajan R; Roy I; Samson B; Sidéris L; Vincent F
Gynecol Oncol; 2013 Oct; 131(1):231-40. PubMed ID: 23872191
[TBL] [Abstract][Full Text] [Related]
3. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
4. Treatment options for advanced endometrial carcinoma.
Dizon DS
Gynecol Oncol; 2010 May; 117(2):373-81. PubMed ID: 20223510
[TBL] [Abstract][Full Text] [Related]
5. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
6. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
[TBL] [Abstract][Full Text] [Related]
7. Uterine carcinosarcoma.
El-Nashar SA; Mariani A
Clin Obstet Gynecol; 2011 Jun; 54(2):292-304. PubMed ID: 21508698
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant treatment for early-stage endometrial cancer.
Zighelboim I; Powell MA
Clin Obstet Gynecol; 2011 Jun; 54(2):245-55. PubMed ID: 21508694
[TBL] [Abstract][Full Text] [Related]
9. Recurrent endometrial cancer.
Del Carmen MG; Boruta DM; Schorge JO
Clin Obstet Gynecol; 2011 Jun; 54(2):266-77. PubMed ID: 21508696
[TBL] [Abstract][Full Text] [Related]
10. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
11. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
12. Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer.
Havrilesky LJ; Secord AA; O'Malley DM; Broadwater G; Bae-Jump V; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Aug; 114(2):279-83. PubMed ID: 19446319
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy in metastatic or recurrent endometrial carcinoma].
Deppe G; Baumann P; Munkarah A
Zentralbl Gynakol; 2000; 122(7):355-60. PubMed ID: 10951705
[TBL] [Abstract][Full Text] [Related]
14. Endometrial cancer in premenopausal women 45 years and younger.
Gitsch G; Hanzal E; Jensen D; Hacker NF
Obstet Gynecol; 1995 Apr; 85(4):504-8. PubMed ID: 7898824
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.
Havrilesky LJ; Cragun JM; Calingaert B; Alvarez Secord A; Valea FA; Clarke-Pearson DL; Berchuck A; Soper JT
Gynecol Oncol; 2007 Feb; 104(2):401-5. PubMed ID: 17014898
[TBL] [Abstract][Full Text] [Related]
16. Update in the management of endometrial cancer.
Levine DA; Hoskins WJ
Cancer J; 2002; 8 Suppl 1():S31-40. PubMed ID: 12075700
[TBL] [Abstract][Full Text] [Related]
17. Systemic therapy for recurrent endometrial cancer: a review of North American trials.
Dellinger TH; Monk BJ
Expert Rev Anticancer Ther; 2009 Jul; 9(7):905-16. PubMed ID: 19589030
[TBL] [Abstract][Full Text] [Related]
18. [Activity of paclitaxel, epirubicin and carboplatin in patients with advanced or recurrent endometrial cancer].
Nakashima R; Enomoto T; Murata Y; Fujita M
Nihon Rinsho; 2004 Oct; 62 Suppl 10():360-4. PubMed ID: 15535268
[No Abstract] [Full Text] [Related]
19. Current treatment strategies for endometrial cancer.
Fiorelli JL; Herzog TJ; Wright JD
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1149-57. PubMed ID: 18588459
[TBL] [Abstract][Full Text] [Related]
20. Developments in the systemic treatment of endometrial cancer.
Mountzios G; Pectasides D; Bournakis E; Pectasides E; Bozas G; Dimopoulos MA; Papadimitriou CA
Crit Rev Oncol Hematol; 2011 Sep; 79(3):278-92. PubMed ID: 20833559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
